OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS
SCIENTIFIC ADVISORY BOARD
Picture


​

Prof. Jeffrey ALMOND, PhD
Chairman of the Scientific Advisory Board

Prof. Jeffrey Almond is a pre-eminent vaccinologist. He has more than forty years of expertise in the field of vaccines and Influenza

Expertise:
  • His scientific contributions include the first demonstration that a single gene can determine host range – a finding highly relevant to understanding evolution of new Influenza pandemic strains
  • Completion of the genetic map of an avian influenza virus
  • First detailed description of the proteins of Influenza B virus
  • Major contributions to the understanding of polio virus and its vaccines

Prior Experience:
  • Consultant and Scientific Advisory, multiple SABs public sector and Biotech companies (2016-present)
  • Visiting Professor, University of Oxford and University of Reading, UK (2016-present)
  • VP and Head of Discovery Research and External R&D, Sanofi Pasteur (1999-2013)
  • Professor, University of Reading, UK (1985-1999)
  • Lecturer, University of Leicester (1979-1985)

Award:
  • Oxford Martin Fellow with the Oxford Martin Programme on Vaccines
  • Elected Fellow of the American Academy of Microbiology
  • Fellow of the UK Academy of Medical Sciences
  • Ivanovsky Medal, Scientific Council of Virology, Russian Academy of Medical Sciences (1999)
  • Fleming Award (1985)

Education:
  • PhD of Philosophy, Virology, University of Cambridge, UK (1974-1976)
  • BSc, Microbiology and Biochemistry combined honours, University of Leeds, UK (1969-1973)
return
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • LEGAL MENTIONS